Human effector memory T cells express CD86: a functional role in naive T cell priming. 1999

P Jeannin, and N Herbault, and Y Delneste, and G Magistrelli, and S Lecoanet-Henchoz, and G Caron, and J P Aubry, and J Y Bonnefoy
Centre d'Immunologie Pierre Fabre, Saint-Julien en Genevois, France. pascale.jeannin@pierre-fabre.com

The glycoprotein CD86 expressed on APCs provides a costimulatory signal necessary for an efficient activation of naive T cells. In contrast, there is controversy about the condition of expression and the function of CD86 on T cells. In this study, we have analyzed the phenotype and the biological activity of CD86+ T cells generated from human PBMC. Results show that CD86 expression on T cells is induced by long term stimulation via CD3 and IL-2R and is down-regulated as the cells become quiescent. The CD86-expressing cells are memory effector T cells: 1) they express CD45RO and high levels of the activation markers CD25, CD54, and HLA-Dr; 2) they selectively express CD30, CD40-ligand, and CD70; and 3) in response to stimulation, most of them produce IFN-gamma before dying by apoptosis. We then analyzed whether CD86 expressed on T cells is functional. Results show that paraformaldehyde-fixed CD86+ T cells enhance the proliferation and production of IFN-gamma by anti-CD3 mAb-stimulated naive T cells and induce proliferation of resting allogenic T cells. All these effects are prevented by neutralizing anti-CD86 mAbs. In contrast, we report no autocrine effect of CD86 in CD86+ T cell activation. In conclusion, these data show that human memory effector T cells express a functional form of CD86 that can costimulate naive T cell responses.

UI MeSH Term Description Entries
D007156 Immunologic Memory The altered state of immunologic responsiveness resulting from initial contact with antigen, which enables the individual to produce antibodies more rapidly and in greater quantity in response to secondary antigenic stimulus. Immune Memory,Immunological Memory,Memory, Immunologic,Immune Memories,Immunologic Memories,Immunological Memories,Memory, Immune,Memory, Immunological
D007399 Interphase The interval between two successive CELL DIVISIONS during which the CHROMOSOMES are not individually distinguishable. It is composed of the G phases (G1 PHASE; G0 PHASE; G2 PHASE) and S PHASE (when DNA replication occurs). Interphases
D007959 Lymphocyte Culture Test, Mixed Measure of histocompatibility at the HL-A locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way MLC test, the lymphocytes from one of the individuals are inactivated (usually by treatment with MITOMYCIN or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens. Leukocyte Culture Test, Mixed,Mixed Lymphocyte Culture Test,Mixed Lymphocyte Reaction,Mixed Leukocyte Culture Test,Mixed Leukocyte Reaction,Leukocyte Reaction, Mixed,Leukocyte Reactions, Mixed,Lymphocyte Reaction, Mixed,Lymphocyte Reactions, Mixed,Mixed Leukocyte Reactions,Mixed Lymphocyte Reactions
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015703 Antigens, CD Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation. CD Antigen,Cluster of Differentiation Antigen,Cluster of Differentiation Marker,Differentiation Antigens, Leukocyte, Human,Leukocyte Differentiation Antigens, Human,Cluster of Differentiation Antigens,Cluster of Differentiation Markers,Antigen Cluster, Differentiation,Antigen, CD,CD Antigens,Differentiation Antigen Cluster,Differentiation Marker Cluster,Marker Cluster, Differentiation
D016130 Immunophenotyping Process of classifying cells of the immune system based on structural and functional differences. The process is commonly used to analyze and sort T-lymphocytes into subsets based on CD antigens by the technique of flow cytometry. Lymphocyte Immunophenotyping,Lymphocyte Subtyping,Immunologic Subtyping,Immunologic Subtypings,Lymphocyte Phenotyping,Subtyping, Immunologic,Subtypings, Immunologic,Immunophenotyping, Lymphocyte,Immunophenotypings,Immunophenotypings, Lymphocyte,Lymphocyte Immunophenotypings,Lymphocyte Phenotypings,Lymphocyte Subtypings,Phenotyping, Lymphocyte,Phenotypings, Lymphocyte,Subtyping, Lymphocyte,Subtypings, Lymphocyte
D016176 T-Lymphocyte Subsets A classification of T-lymphocytes, especially into helper/inducer, suppressor/effector, and cytotoxic subsets, based on structurally or functionally different populations of cells. T-Cell Subset,T-Cell Subsets,T-Lymphocyte Subset,Subset, T-Cell,Subset, T-Lymphocyte,Subsets, T-Cell,Subsets, T-Lymphocyte,T Cell Subset,T Cell Subsets,T Lymphocyte Subset,T Lymphocyte Subsets
D051940 B7-2 Antigen A costimulatory ligand glycoprotein that contains a C2 and V-type IMMUNOGLOBULIN DOMAIN. It is expressed by ANTIGEN-PRESENTING CELLS and binds to CD28 ANTIGEN with high specificity and to CTLA-4 ANTIGEN with low specificity. The interaction of CD86 with CD28 ANTIGEN provides a stimulatory signal to T-LYMPHOCYTES, while its interaction with CTLA-4 ANTIGEN may play a role in inducing PERIPHERAL TOLERANCE. Antigens, CD86,B7-2 Costimulatory Molecule,CD86 Antigens,Antigen, B7-2,B70 Costimulatory Molecule,CD86 Antigen,Early T Cell Costimulatory Molecule 1,Antigen, B7 2,Antigen, CD86,B7 2 Antigen,Costimulatory Molecule, B7-2,Costimulatory Molecule, B70

Related Publications

P Jeannin, and N Herbault, and Y Delneste, and G Magistrelli, and S Lecoanet-Henchoz, and G Caron, and J P Aubry, and J Y Bonnefoy
July 2018, Journal of immunology (Baltimore, Md. : 1950),
P Jeannin, and N Herbault, and Y Delneste, and G Magistrelli, and S Lecoanet-Henchoz, and G Caron, and J P Aubry, and J Y Bonnefoy
January 2018, Frontiers in immunology,
P Jeannin, and N Herbault, and Y Delneste, and G Magistrelli, and S Lecoanet-Henchoz, and G Caron, and J P Aubry, and J Y Bonnefoy
June 1994, Current opinion in immunology,
P Jeannin, and N Herbault, and Y Delneste, and G Magistrelli, and S Lecoanet-Henchoz, and G Caron, and J P Aubry, and J Y Bonnefoy
August 2023, Current opinion in immunology,
P Jeannin, and N Herbault, and Y Delneste, and G Magistrelli, and S Lecoanet-Henchoz, and G Caron, and J P Aubry, and J Y Bonnefoy
January 2005, Current topics in microbiology and immunology,
P Jeannin, and N Herbault, and Y Delneste, and G Magistrelli, and S Lecoanet-Henchoz, and G Caron, and J P Aubry, and J Y Bonnefoy
January 2005, Journal of leukocyte biology,
P Jeannin, and N Herbault, and Y Delneste, and G Magistrelli, and S Lecoanet-Henchoz, and G Caron, and J P Aubry, and J Y Bonnefoy
October 2001, The Journal of experimental medicine,
P Jeannin, and N Herbault, and Y Delneste, and G Magistrelli, and S Lecoanet-Henchoz, and G Caron, and J P Aubry, and J Y Bonnefoy
December 2001, The Journal of experimental medicine,
P Jeannin, and N Herbault, and Y Delneste, and G Magistrelli, and S Lecoanet-Henchoz, and G Caron, and J P Aubry, and J Y Bonnefoy
October 2018, Science translational medicine,
P Jeannin, and N Herbault, and Y Delneste, and G Magistrelli, and S Lecoanet-Henchoz, and G Caron, and J P Aubry, and J Y Bonnefoy
December 2006, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!